Loading…
Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review
Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellula...
Saved in:
Published in: | Cancer control 2024-01, Vol.31, p.10732748241287905 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3 |
container_end_page | |
container_issue | |
container_start_page | 10732748241287905 |
container_title | Cancer control |
container_volume | 31 |
creator | Gao, Renzhuo Zhou, Dan Qiu, Xingpeng Zhang, Jiayi Luo, Daya Yang, Xiaohong Qian, Caiyun Liu, Zhuoqi |
description | Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized. |
doi_str_mv | 10.1177/10732748241287905 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_acf6bd9748024320a1d341f930721b79</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_acf6bd9748024320a1d341f930721b79</doaj_id><sourcerecordid>3108762555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</originalsourceid><addsrcrecordid>eNplkU1v1DAQhi0Eoh_wA7ggH7ks-DOOuaAqorTSIiooXK2JM9l1lY0XOynqv8dhS0XFyZbfd54Zz0vIK87ecm7MO86MFEbVQnFRG8v0E3LMtahWQmr7tNyLvloMR-Qk5xvGBFNSPSdH0koulRLHBBsYPSZ6vcUEe5yn4OlVnHCcAgwUxo5epbgZY16EHzDMSGNPpy3Sb-tGaPo5TNFv49ilxd9ASqHQzmEXhrv39Ix-xduAv16QZz0MGV_en6fk-_nH6-Zitf7y6bI5W6-8VPVURmVtp3ttrdU9VGhVC22vJdNYM89Fy1oUyHytjNBKSKuYrVEyVL6DqvLylFweuF2EG7dPYQfpzkUI7s9DTBsHqfxkQAe-r9rOluUwoaRgwDupeG8lM4K3xhbWhwNrP7c77HxZSYLhEfSxMoat28Rbx7mSltcL4c09IcWfM-bJ7UL2OAwwYpyzk5zVphJa62LlB6tPMeeE_UMfztyStfsv61Lz-t8BHyr-hit_AzNroy0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108762555</pqid></control><display><type>article</type><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><source>Open Access: PubMed Central</source><source>SAGE Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</creator><creatorcontrib>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</creatorcontrib><description>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</description><identifier>ISSN: 1073-2748</identifier><identifier>ISSN: 1526-2359</identifier><identifier>EISSN: 1526-2359</identifier><identifier>DOI: 10.1177/10732748241287905</identifier><identifier>PMID: 39313442</identifier><language>eng</language><publisher>United States: SAGE Publications</publisher><subject>Biomarkers, Tumor - metabolism ; Humans ; Mitochondria - metabolism ; Mitochondrial Membrane Transport Proteins - metabolism ; Mitochondrial Proteins ; Neoplasms - metabolism ; Neoplasms - therapy ; Organic Anion Transporters ; Prognosis ; Review</subject><ispartof>Cancer control, 2024-01, Vol.31, p.10732748241287905</ispartof><rights>The Author(s) 2024 2024 SAGE Publications Inc, unless otherwise noted. Manuscript content on this site is licensed under Creative Common Licences</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</cites><orcidid>0000-0001-6985-3173 ; 0009-0007-3936-0096 ; 0000-0003-1227-2436 ; 0009-0007-4415-5409 ; 0009-0006-3698-2036 ; 0009-0004-8210-5646 ; 0000-0002-7293-0886</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439189/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439189/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39313442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Renzhuo</creatorcontrib><creatorcontrib>Zhou, Dan</creatorcontrib><creatorcontrib>Qiu, Xingpeng</creatorcontrib><creatorcontrib>Zhang, Jiayi</creatorcontrib><creatorcontrib>Luo, Daya</creatorcontrib><creatorcontrib>Yang, Xiaohong</creatorcontrib><creatorcontrib>Qian, Caiyun</creatorcontrib><creatorcontrib>Liu, Zhuoqi</creatorcontrib><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><title>Cancer control</title><addtitle>Cancer Control</addtitle><description>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Humans</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondrial Membrane Transport Proteins - metabolism</subject><subject>Mitochondrial Proteins</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - therapy</subject><subject>Organic Anion Transporters</subject><subject>Prognosis</subject><subject>Review</subject><issn>1073-2748</issn><issn>1526-2359</issn><issn>1526-2359</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNplkU1v1DAQhi0Eoh_wA7ggH7ks-DOOuaAqorTSIiooXK2JM9l1lY0XOynqv8dhS0XFyZbfd54Zz0vIK87ecm7MO86MFEbVQnFRG8v0E3LMtahWQmr7tNyLvloMR-Qk5xvGBFNSPSdH0koulRLHBBsYPSZ6vcUEe5yn4OlVnHCcAgwUxo5epbgZY16EHzDMSGNPpy3Sb-tGaPo5TNFv49ilxd9ASqHQzmEXhrv39Ix-xduAv16QZz0MGV_en6fk-_nH6-Zitf7y6bI5W6-8VPVURmVtp3ttrdU9VGhVC22vJdNYM89Fy1oUyHytjNBKSKuYrVEyVL6DqvLylFweuF2EG7dPYQfpzkUI7s9DTBsHqfxkQAe-r9rOluUwoaRgwDupeG8lM4K3xhbWhwNrP7c77HxZSYLhEfSxMoat28Rbx7mSltcL4c09IcWfM-bJ7UL2OAwwYpyzk5zVphJa62LlB6tPMeeE_UMfztyStfsv61Lz-t8BHyr-hit_AzNroy0</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Gao, Renzhuo</creator><creator>Zhou, Dan</creator><creator>Qiu, Xingpeng</creator><creator>Zhang, Jiayi</creator><creator>Luo, Daya</creator><creator>Yang, Xiaohong</creator><creator>Qian, Caiyun</creator><creator>Liu, Zhuoqi</creator><general>SAGE Publications</general><general>SAGE Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6985-3173</orcidid><orcidid>https://orcid.org/0009-0007-3936-0096</orcidid><orcidid>https://orcid.org/0000-0003-1227-2436</orcidid><orcidid>https://orcid.org/0009-0007-4415-5409</orcidid><orcidid>https://orcid.org/0009-0006-3698-2036</orcidid><orcidid>https://orcid.org/0009-0004-8210-5646</orcidid><orcidid>https://orcid.org/0000-0002-7293-0886</orcidid></search><sort><creationdate>202401</creationdate><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><author>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Humans</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondrial Membrane Transport Proteins - metabolism</topic><topic>Mitochondrial Proteins</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - therapy</topic><topic>Organic Anion Transporters</topic><topic>Prognosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Renzhuo</creatorcontrib><creatorcontrib>Zhou, Dan</creatorcontrib><creatorcontrib>Qiu, Xingpeng</creatorcontrib><creatorcontrib>Zhang, Jiayi</creatorcontrib><creatorcontrib>Luo, Daya</creatorcontrib><creatorcontrib>Yang, Xiaohong</creatorcontrib><creatorcontrib>Qian, Caiyun</creatorcontrib><creatorcontrib>Liu, Zhuoqi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Cancer control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Renzhuo</au><au>Zhou, Dan</au><au>Qiu, Xingpeng</au><au>Zhang, Jiayi</au><au>Luo, Daya</au><au>Yang, Xiaohong</au><au>Qian, Caiyun</au><au>Liu, Zhuoqi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</atitle><jtitle>Cancer control</jtitle><addtitle>Cancer Control</addtitle><date>2024-01</date><risdate>2024</risdate><volume>31</volume><spage>10732748241287905</spage><pages>10732748241287905-</pages><issn>1073-2748</issn><issn>1526-2359</issn><eissn>1526-2359</eissn><abstract>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</abstract><cop>United States</cop><pub>SAGE Publications</pub><pmid>39313442</pmid><doi>10.1177/10732748241287905</doi><orcidid>https://orcid.org/0000-0001-6985-3173</orcidid><orcidid>https://orcid.org/0009-0007-3936-0096</orcidid><orcidid>https://orcid.org/0000-0003-1227-2436</orcidid><orcidid>https://orcid.org/0009-0007-4415-5409</orcidid><orcidid>https://orcid.org/0009-0006-3698-2036</orcidid><orcidid>https://orcid.org/0009-0004-8210-5646</orcidid><orcidid>https://orcid.org/0000-0002-7293-0886</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-2748 |
ispartof | Cancer control, 2024-01, Vol.31, p.10732748241287905 |
issn | 1073-2748 1526-2359 1526-2359 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_acf6bd9748024320a1d341f930721b79 |
source | Open Access: PubMed Central; SAGE Open Access; Publicly Available Content (ProQuest) |
subjects | Biomarkers, Tumor - metabolism Humans Mitochondria - metabolism Mitochondrial Membrane Transport Proteins - metabolism Mitochondrial Proteins Neoplasms - metabolism Neoplasms - therapy Organic Anion Transporters Prognosis Review |
title | Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A30%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20Therapeutic%20Potential%20and%20Prognostic%20Value%20of%20the%20SLC25%20Mitochondrial%20Carrier%20Family:%20A%20Review&rft.jtitle=Cancer%20control&rft.au=Gao,%20Renzhuo&rft.date=2024-01&rft.volume=31&rft.spage=10732748241287905&rft.pages=10732748241287905-&rft.issn=1073-2748&rft.eissn=1526-2359&rft_id=info:doi/10.1177/10732748241287905&rft_dat=%3Cproquest_doaj_%3E3108762555%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3108762555&rft_id=info:pmid/39313442&rfr_iscdi=true |